Systemic hyperinsulinaemia induces vasodi latation in human skeletal muscle. This effect is gra dual in onset, and at low insulin levels not maximal until at least 3 h. To investigate whether the vasodi lator response to insulin results from a direct vascular effect, we infused insulin directly into the cannulated brachial artery (perfused forearm technique) in a total of 30 experiments in 20 healthy, lean, normotensive volunteers. Local, intra-arterial, infusion of insulin (180 min, O O m U dL " 1 forearm volumemin" 1, « = 15, forearm venous insulin concentration approximately 540pm olL -1) induced a gradual increase in forearm blood flow (FBF; venous occlusion plethysmography) from 1-86 ± 0*17 to 3*64 ± 0,6 4 m L d L " 1 min~l after 180 min (a n o v a P < 0-001), Percentage increases in FBF after 60, 120 and 180 min averaged 14*4 ± 5-9, 59*4 ± 25*5 and 124*6 ± 51*2% respectively. Fore arm glucose uptake increased from 0*24 ± 0-05 to a maximum of 1*98 ± 0-28 /.¿moldL~l min (P < 0 001). Furthermore, insulin infusion increased forearm lac tate release and potassium uptake. In 10 out of these 15 individuals, the forearm glucose uptake was further increased in a second, separate, repeat experiment with concomitant intra-arterial infusion of glucose 5%
Introduction
In acute experiments in humans, systemic insulin infusion with maintenance of euglycaemia, exerts a vasodilator effect in skeletal muscle [1 -3] . This insulininduced vasodilatation has been found to be reduced in disorders characterized by insulin resistance such as obesity [1] , hypertension [4] and non-insulin-dependent diabetes mellitus (NIDDM) [5] . As insulin-mediated skeletal muscle vasodilatation significantly contributes to the disposal of glucose, a diminished vasodilator capacity in itself explains part of the decreased insulin sensitivity in insulin-resistant states [1, 4, 5] . Therefore, further research on the phenomenon of insulin-induced vasodilatation may be of clinical importance.
Controversy exists as to whether the vasodilator response to physiological hyperinsulinaemia results from a direct effect of insulin on the vascular wall. Whereas some authors have found an increase in blood flow in response to local insulin administration [6, 7] , others have not [8] [9] [10] . Based on the latter findings it has been concluded that the insulin-induced vasodilatation is centrally mediated [11, 12] . In the present study we have carefully investigated the effect of regional hyperinsulinaemia on the putative vasodilatation in the skeletal muscle vascular bed, with special attention to the time course. Until now very little attention has been given to the time course of the insulin-induced vasodilator effect, which may be an important clue with respect to the controversial observations in the literature. From data o f Laakso et a l [1] , it is obvious that the vasodilator effect of systemic insulin infusion (physiological plasm a insulin concentrations) is not maximal until 3 h o f infusion, and that after 30 and 60 min, respectively, only approximately 10% and approximately 30% of the maximum effect has been reached. Recently, even slower increases in blood flow in response to insulin have been reported [13, 14] . On the other hand, several studies in which insulin was administered locally have used only 20-30 min of infusion time [9, 10, 15] .
Finally, as insulin-mediated glucose uptake m ay be an important determinant of the vasoactive effects of 772 (b 1996 Blackwell Science Ltd insulin [14, 16] , this parameter was measured through out our studies and was artificially z*aised in a sub group by regional glucose infusion.
Methods

Subjects
The study group consisted of 20 healthy volunteers. All met the inclusion criteria: age between 18 and 35 years, non-smoking, absence of hypertension (office blood pressure < 140/90 mmHg, measured after 5 min rest in the supine position), body mass index < 25kgm -2. Participants used no medication, with the exception of oral contraceptives. The participants were selected by advertisement and received a payment. All subjects had a negative family history of diabetes and hypertension. All participants gave written informed consent. The experimental protocol was approved by the hospital ethics committee.
Procedures
The experiments were performed with the subjects in supine position after an overnight fast, in a quiet, temperature-controlled room (23-24°C) . Under local anaesthesia (0*3-0-4mL lidocaine HCl 20m gm L"1), a 20-gauge catheter (Angiocath, Becton Dickinson, Sandy, UT, USA) was inserted into the left brachial artery and connected with an arterial pressure moni toring line (Viggo Spectramed, 5269-129) to a Hewlett Packard 78353B Monitor. Mean arterial pressure (MAP) was determined by the electronically integrated area under the brachial arterial pulse-wave curve. The arterial line was kept patent with saline infusion (3m Lh-1 with 2U heparin m L "1 added). In the same arm a catheter (Venfion, 20G, 32mm) was inserted retrogradely into a deep forearm vein to obtain venous blood samples. On the contralateral side an identical catheter was inserted into a large forearm vein for blood sampling.
Forearm volume (FAV) was measured with the water displacement method. Forearm blood flow (FBF) was measured simultaneously in both arms, with the arms elevated just above heart level, using mercury-in-silastic strain-gauge venous occlusion plethysmography as previously described [17] . FBF was expressed in mL dL~1 FAV min" 1, and in the text 1 1 abbreviated to m LdL min . One minute before the start of the measurements, a wrist cuff was inflated to lOOmmHg above systolic blood pressure. The collect ing cuff around the upper arm was inflated to a pressure of 40mjmHg during eight heart cycles using a Hokanson E20 rapid cuff inflator. The strain gauges were connected with the Hokanson EC4 plethysmographs. During a measurement period, 8-10 measure ments of FBF were performed, each lasting approximately eight heart cycles. Net uptake or release of glucose, lactate and potas sium was calculated by simultaneous arterial and venous blood sampling (see calculations). Venous blood was sampled while the wrist cuffs remained inflated. Samples for insulin, potassium, lactate and pyruvate were taken at hourly intervals.
P rotocols
Insulin ( I ) experim en ts. in 15 individuals, after complete instrumentation, at least 30 min of rest were included to obtain a steady state, after which baseline measurements were performed and repeated after 15 min. When FBF was stable, insulin (Actrapid, Novo-Nordisk, Denmark) was infused into the bra chial artery, at a dose of 0-3 mU d L _I m in"1 (volume 50 ¡j,LdL min" 1) and continued for 180 min. Insulin 50 U m L "1 was twice diluted in lOOmL of 0*9% NaCl each time with the addition of 2 mL of human albumin 20% (Central Laboratory of Blood transfu sion, Amsterdam). FBF was measured after 5,15 and thereafter every 15 min until 180 min.
Insulin ~h glucose ( I -J-G ) ex p erim en ts. In 10 indi viduals, randomly selected out of the 15 who had participated in the first protocol, the entire experiment was repeated after at least 4 weeks, but now with the addition of 0*2m L dL '"1 m in '1 glucose 5% infusion.
C on trol ( C ) experim ents.
In five different indivi duals, time and vehicle control experiments were performed, following exactly the same protocol, but now saline with the addition of albumin 20% (as mentioned above) was infused into the brachial artery for 180 min.
A n a ly tic a l m ethods. Plasma glucose was measured in duplicate using the glucose oxidation method (Beckman glucose analyzer 2, Beckman Instruments, Fullerton, CA, USA).
Plasma insulin was measured with an in-house double antibody radioimmunoassay (interassay coeffi cient of variation 6*2%). For quantification of L-lactate (and pyruvate) in deproteinized blood (6% perchloric acid) an enzymatic assay (Lactate UV-kit; Boehringer Mannheim, Mannheim, Germany) with L-lactate dehydrogenase (L-LDH; EC 1.1.1.27) was performed. Because pyruvate concentrations remained at or below detection limit, these results were not used for further analyses. Potassium was measured with a standard procedure using a K +-ion selective electrode with a Hitachi 747 autoanalyser (Boehringer Mannheim). Effects of insulin on haemodynamic parameters were analysed using one-way repeated measures a n o v a , with insulin as dependent factor. Post hoc /-tests were performed to test differences of the various time points from baseline. The effect o f insulin alone was compared with the effect of insulin + glucose with the use of a two-way a n o v a for paired observations, with insulin and insulin -I-glucose as dependent vari ables. All other (mainly metabolic) data met require ments o f normality and were statistically analysed with the use o f Student's Kest, Correlations were calculated using Spearman's rank correlation tests. For the rela tion between venous insulin concentrations and forearm glucose extraction [(GA -G V)GA"1], linear regression was perfonned and the coefficients of regression were used for further analysis. All statistical analyses were performed using the SPSS personal computer software package.
Results in tables and figures are expressed as mean ± SEM, unless otherwise indicated. Statistical significance was set at a value less than 0*05 (twosided). NS means not significant.
i
Results
Base! in e ch ara c for is t i cs
Baseline characteristics of the three study groups are given in Table 1 . Participants were lean, young, normotensive and had a strictly normal fasting glu cose level.
Vascular responses to local hyperinsulinaemia
Insulin infusion led to deep venous forearm insu lin concentrations of 549 ± 43, 497 ± 53 and 404 ± 50pmol L 1 after 60, 120 and 180 in respec tively, whereas arterial levels did not increase: 57 ± 5, 57 ± 4, 54 ± 4 and 49 ± 4pm ol L -1 (baseline, 60, 120 and 180 min respectively).
Local infusion of insulin induced a highly signi ficant increase in forearm blood flow over time, from 1 *86 ± 0-17 to 3*64 ± 0*64mL dL~1 min ( a n o v a P < 0*001). This vasodilatation did not occur before 15 min, and was significantly different from baseline after 30 min. As can be seen in Fig. 1 , the increase in FBF was gradual and even after 180 min, FBF did not seem to have reached a steady state. The increase in flow was attended by a significant decrease in FVR from 49*4 ± 3*6 to 33*1 ±4*2 AU ( a n o v a P < 0*001). Also the control arm showed a slight increase in FBF over time (FBF from 1*57 ±0*16 to l , ANOVA P -0*061), but the FBFcxpcrimental/FBP1 control arm iatÍO inCLeased SÍg niñcantly (from 1*26 ±0*09 to 1*67 ±0*15, a n o v a P < 0*001), proving a true regional effect of insulin infusion [18], min
Metabolic responses to local hyper insulinaemia
Arterial forearm glucose values did not change, whereas venous forearm glucose levels decreased to trough levels at 30 min and increased slightly after wards (see Fig. 1 ). Calculated forearm glucose uptake increased from 0*24 ± 0*05 to a maximum of 1*98 ± 0*28 /¿moldL" 1 min" 1 (at 30 min, P < 0*001) and decreased slightly afterwards to 1*29 ± 0T9 after 180 min (P < 0*01 vs. 30 min).
Insulin infusion increased forearm lactate release (from baseline 70 ±27 to 340 ± 52 nmol dL 1 min after 120min, P<0*01) and uptake of potassium (from -0-17 ±0-05 to 0-24 ± 0-15/iinoldL "1 m in -1, P < 0*05, see also Table 2 ). No significant correlations were found between changes in mctabolic parameters and blood flow changes. Inherent to its metabolic effect, a positive relationship was observed between deep venous insulin concentrations and glucose extraction across the forearm vascular bed (P < 0*01).
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Eff'e c ts of the a cldi l io n of g lu c ose
Infusion of glucose into the brachial artery led to venous glucose concentrations of approximately IS m m olL -1 (13*8 zb 1-0, 14*2 ± 1*0, 14*4 ±0*9, 15*9 ± 1*6, 15*2 ± 0*8 and 15*6 ± 1*8 mmol L~ \ after 30, 60, 90, 120, 150 and 180 min respectively). Sys temic venous glucose levels (measured at contralateral side) remained approximately 5 mmol L" 1 (4-7 ± 0*1, 4-8 ±0*1 and 4*9 ± 0T mmol L~\ after 60, 120 and 180 min respectively). Venous insulin levels were com parable with those in the first set of experiments (568 ± 67, 637 ± 67 and 566 ± 89 pmol L~1, after 60, 120 and 180 min respectively). The combination of hyperinsulinaemia and hyperglycaemia induced a sig nificant increase in flow (FBFcxperimenmi arm from 2-03 ±0-29 to 2-79 ± 0-28 m LdL-1 min-1 after 180min, a n o v a P < O'Ol, see Fig, 2 ), whereas FBF in the control arm did not change (from 2T 3 ± 0-47 to 2-34 ± 0-54mLdL~' min-1, P = NS). Comparing the paired data sets of insulin alone vs. insulin + glucose infusion (tf=10), no significant difference in the FBF changes between the two experi ments was observed (FBFexperimentai arm, insulin alone (I): from 1-63 ±0-12 to 1-78 ±0-12, 2*04 ±0*23, 2*66 ± 0'32mLdL~J min" 1; insulin + glucose (I ± G): During I + G, forearm lactate release (P = 0*012) and potassium uptake (P = 0*086) reached higher levels than during I alone (see Table 2 ), indicating a local increase of metabolic pathways.
Time (min)
A significant correlation between the percentage increase in FBF during I alone and during concomi tant I 4-G was established on various lime points. In Fig. 3 the correlation at 90 min is shown: r = 0-87, P = 0*001.
Vascular responses to sham procedure
In the control experiment, FBF did not change during Table 2 . Lactate release and potassium uptake at different time points (mean-rt SE) 180 min intra-arterial infusion of saline + albumin (2-25 ±0-41, 2'10 ± 0-34, 1-85 ± 0-23, 2-00 J -0-25, 1 • 83 ± 0-22,1 -76 ± 0-18 and 1 -9 ± 0-21 mL dL "1 m in"', baseline, 30, 60, 90, 120,150 and 180 min respectively), Arterial and venous glucose concentrations as well as forearm glucose uptake remained at fasting levels (data not shown).
Change in FBF (%), insulin alone
Discussion
The major new finding of the present study is that local insulin administration in the vascular bed of the human forearm skeletal muscle, leading to fore arm deep venous insulin levels in the physiological range, induces a moderate, but reproducible, degree of vasodilatation. This, however, is slow in onset and preceded by maximal forearm glucose-uptake. In fact, the time course of the vasodilatation is very similar to that found with systemic insulin administra tion, leading to similar insulin levels [13] . Furthermore artificial raising of glucose uptake by local hyperglycaemia did not influence the vasodilator response to insulin. In recent years, various investigators, including ourselves, have shown the vasodilator capacities of insulin [1] [2] [3] . Interestingly, in various related disorders such as obesity, hypertension and NIDDM, character ized by insulin resistance [19, 20] , a decreased insulininduced vasodilatation has also been reported [1, 4, 5] . The mechanism by which insulin exerts vasodilator effects could therefore be of great importance. Although not fully understood up to now, recent data seem to point towards a nitric oxide-dependent mechanism of action [7, 21] . One of the controversies is whether the vasodilator response results from a direct effect on the vascular wall or from an indirect, possibly central, mechanism [22] . In favour of the latter hypothesis is the fact that several investigators were not able to show any vasodilatation when insulin was infused locally [X 10,23).
Until now little attention has been given to the time course of insulin-induced vasodilatation or to the relation between the speed of onset of the vasodilator effect and the insulin (and glucose) concentration. From the data available, it is clear that during euglv* eaemie systemic hyperinsulinaemia, insulin-induced vasodilatation is slow in onset and takes at least 3h to obtain its maximal effect at physiological concen trations [1, 13] . This is considerably longer than the time needed to reach maximal glucose uptake [1, 16] and means that in studying blood fiow responses to insulin, not only concentration but also duration of infusion mav be critical (which will also hold true for m local infusion). In keeping with this, Lundgren et al. [24] , reported an increase in calf blood How from 2'3 to 3*2 after 2 h, but even further to 4*4 m l. dL 1 min 1 after 6h of a iixed-dose insulin infusion.
Therefore it is obvious that in studying local vasodilator effects of insulin, sufficient time should be taken to allow' insulin to exhibit its full effects, as we did in this study. This fact could explain why some authors were not able to identify anv local action of * » insulin, as a number of investigators infused insulin lor only 20 30min [9JO, 15) . Gelfand & Barrett (25| established a small increase in blood How alter SI) min, as did Neahring ct a i [26|, and Jern [27) , using a paired study approach (2-h local insulin infusion). It can be speculated that at higher insulin concentrations the vasodilator effect will appear earlier, and hence be found after 15 30 min [6, 7] . In our study, the individual response to insulin, although reproducible, showed a high variability, ranging from no effect to more than doubling of the blood flow ( Fig. 3 ). This high intormdividual variation has also been reported by others and related to the relative forearm muscle content [ 14] . Thus, studies with small sample sizes, have a con siderable risk of a type 2 statistical error, which could have further contributed to the controversial (indiims up to now, Whereas we show in this study that at least part of insulin's vasodilator action can be explained by a local effect on the vascular wall, our study was not intended to explain the exact mechanism of insulin's effect. It seems that insulin-mediated glucose uptake precedes vasodilatation in skeletal muscle, but this does not mean that these two actions are coupled. In our own study, the addition of extra glucose, which must certainly have accelerated glucose uptake [ IA K /\i, iiNr)Ui JtN v / \^w i v i u \ i / \ n v ; n they observed were the consequence of prolonged e x p o su re to insulin alone (24|, and not of the higher glycaemie level. Others have found no dilVerences in How in relation to dilVerent glycaemie levels [28). Furthermore, Vollenweider ct <//. [29] have shown that insulin (with glucose) infusion induced vasodila tation, but fructose infusion alone, which increased carbohydrate oxidation comparably but had only minor effects on insulinaemia, did not stimulate skele tal muscle blood flow. As such it may be concluded that there is no lirm evidence that hyperglycaemia augments insulin-induced vasodilatation.
In our study glucose uptake increased rapidly, but then slightly decreased during the subsequent experi ment. During systemic hyperinsulinaemia, this w ^ W t decrease in glucose uptake over time is not observed. This finding is probably related to our experimental approach; owing to the increase in blood How and the lixed insulin infusion rate, forearm insulin con centrations decreased, leading to a decreased glucose extraction. In favour of this explanation is the fact that we found a significant, positive, intra-individual correlation between venous insulin concentrations and glucose uptake. Therefore this secondary decrease in forearm glucose uptake will be related to the experimental model, and hence although partly inevi table, unphysiologieal. During regional hyperinsulinaemia, venous plasma glucose concentrations decreased to hypoglyeaemic levels. It is important to realize that this would also occur in euglycaemie clamps. The term euglycaemia refers to the arterial(ized) glucose concentration, but, owing it) the stimulatory elleet of insulin on glucose uptake, venous glucose concentrations will be con siderably lower. Further, it has to be stressed that, because of the local approach, no systemic hypoglyeaemia occurred in our studies.
We have fount!, as have others [30) , that during local insulin infusion lactate release increases. How ever, there was no correlation established between lactate release and vasodilatation. Furthermore, daring the combination ol*hyperglycaemia and hyperinsulinaemia, lactate release further increased, sug gesting more active metabolic pathways, but the increase in blood How was not a Heeled. Also others have armied that it is unlikely that lactate increase accounts for insulin's vasodilator eiVeet [I],
In conclusion, we report that local hyperinsulinaemia leading to physiological insulin levels in the human forearm induces a slow-onset local vasodilata tion that is preceded by maximal tissue glucose uptake. The time course of the ell eel seems to be similar to that found in studies in which insulin is infused systemicallv and indicates that the insulin-* 1* induced vasodilator eHect is mediated at least partly at the level of the skeletal muscle.
Although insulin-mediated skeletal muscle glucose uptake preceded the vasodilatory eHect, it seems not to be an important determinant of the vasodilator
